Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10988477 GCN2 inhibitors and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Igor Mochalkin0

James Dodd0

Kiri North0

Matthew Bleich0

Meredith Suzanne Eno0

Michael Mortimore0

Pierre-Henri Storck0

Robert Pullin0

...

Date of Patent

April 27, 2021

0

Patent Application Number

162599790

Date Filed

January 28, 2019

0

Patent Citations Received

US Patent 11857551 Methods for the prevention and treatment of hearing loss

0

US Patent 12084438 GCN2 inhibitors and uses thereof

0

US Patent 11945799 4-ethynylpyridine derivatives useful as GCN2 inhibitors

0

Patent Primary Examiner

Emily A Bernhardt

0

Patent abstract

The present invention provides compounds inhibiting General amino acid Control Non-derepressible 2 kinase (“GCN2”), compositions thereof, and methods of using the same for treating various disorders, such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10988477 GCN2 inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool